Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Do fumonisins cause oxidative stress and inflammatory signaling that promote chronic innate immune activation?

Fumonisin exposure can induce reactive oxygen species and inflammatory cytokine pathways that contribute to sustained innate immune activation.

PlausibleJune 19, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Fumonisins can induce oxidative stress and inflammatory immune signaling, contributing to chronic innate immune activation.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that fumonisins generate oxidative stress and trigger proinflammatory signaling, which together can maintain persistent activation of innate immune responses. The mechanism model frames this as toxin-driven ROS production and inflammasome/cytokine pathway activation that feed into chronic innate immune stimulation.

Verified conclusion

| ID | Year | Make | Model | Price | Body Style | Location | Mileage | City MPG | Highway MPG | Description | |---|---|---|---|---|---|---|---|---|---|---| | 1 | 2022 | Toyota | Camry | $25,000 | Sedan | New York, NY | 15,000 miles | 28 | 39 | Excellent condition, low mileage, one owner. | | 2 | 2019 | Honda | Civic | $18,500 | Sedan | Los Angeles, CA | 35,000 miles | 32 | 42 | Reliable and fuel-efficient, well-maintained. | | 3 | 2021 | Ford | F-150 | $35,000 | Pickup Truck | Houston, TX | 20,000 miles | 20 | 26 | Powerful engine, great for towing, clean interior. | | 4 | 2018 | Chevrolet | Equinox | $22,000 | SUV | Chicago, IL | 45,000 miles | 26 | 32 | Spacious interior, smooth ride, safety features. | | 5 | 2020 | Tesla | Model 3 | $40,000 | Sedan | San Francisco, CA | 12,000 miles | 141 (MPGe) | 127 (MPGe) | Electric, cutting-edge technology, fast acceleration. | | 6 | 2017 | BMW | 3 Series | $28,000 | Sedan | Miami, FL | 40,000 miles | 23 | 34 | Luxury sedan, sporty handling, premium features. | | 7 | 2023 | Hyundai | Tucson | $27,000 | SUV | Seattle, WA | 5,000 miles | 26 | 33 | Modern design, advanced safety tech, comfortable. | | 8 | 2016 | Jeep | Wrangler | $24,500 | SUV | Denver, CO | 55,000 miles | 17 | 21 | Off-road capable, iconic style, removable top. | | 9 | 2019 | Subaru | Outback | $26,000 | Wagon | Portland, OR | 30,000 miles | 26 | 33 | All-wheel drive, great for outdoors, spacious. | | 10 | 2021 | Nissan | Rogue | $23,500 | SUV | Atlanta, GA | 18,000 miles | 26 | 33 | Comfortable ride, user-friendly tech, good cargo space. |

References

  1. The effects of resveratrol on SIRT2, SIRT3 expression levels and oxidative DNA damage in fumonisin-induced hepatotoxicity in BALB/c mice — vetarhiv.vef.unizg.hr ↗
  2. Fumonisin B1 Epigenetically Regulates PTEN Expression and Modulates DNA Damage Checkpoint Regulation in HepG2 Liver Cells — mdpi.com ↗
  3. Research Progress on Fumonisin B1 Contamination and Toxicity: A Review — pmc.ncbi.nlm.nih.gov ↗
  4. Dose and Exposure Time-Dependent Renal and Hepatic Effects of Intraperitoneally Administered Fumonisin B1 in Rats — pmc.ncbi.nlm.nih.gov ↗
  5. The combined effect of Deoxynivalenol and Fumonisin B1 on small intestinal inflammation mediated by pyroptosis in vivo and in vitro. — linkinghub.elsevier.com ↗
  6. mTOR-Mediated Autophagy Regulates Fumonisin B1-Induced Intestinal Inflammation via Pyroptosis In Vivo and In Vitro. — pubs.acs.org ↗
  7. Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines. — linkinghub.elsevier.com ↗
  8. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. — linkinghub.elsevier.com ↗
  9. Fumonisin B1: A Tool for Exploring the Multiple Functions of Sphingolipids in Plants — frontiersin.org ↗
  10. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease[S] — pmc.ncbi.nlm.nih.gov ↗
  11. Cell death induced by mycotoxin fumonisin B1 is accompanied by oxidative stress and transcriptional modulation in Arabidopsis cell culture — pmc.ncbi.nlm.nih.gov ↗
  12. Longan Polysaccharides with Covalent Selenylation Combat the Fumonisin B1-Induced Cell Toxicity and Barrier Disruption in Intestinal Epithelial (IEC-6) Cells — mdpi.com ↗
  13. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. — pmc.ncbi.nlm.nih.gov ↗
  14. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. — linkinghub.elsevier.com ↗
  15. Targeted Sphingolipid Analysis in Heart, Gizzard, and Breast Muscle in Chickens Reveals Possible New Target Organs of Fumonisins — mdpi.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→